Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport
ChemMedChem · 2026-10-28 · 21 (20)
DOI: 10.1002/cmdc.70555 ↗At a glance
Journal article in ChemMedChem, published online on 2026-10-26. Written by Irina P Fonareva and 7 co-authors. Institution: Department of Organic Chemistry, Nizhny Novgorod State University, Nizhny Novgorod, Russian Federation. Major MEDLINE topics: Monocarboxylic Acid Transporters, Pyrazoles, Symporters, Lactic Acid. 53 references. Funded by: Russian Science Foundation.
Abstract (original language)
Monocarboxylate transporter 1 (MCT1) represents an attractive therapeutic target as an important regulator of tumor metabolism. In this study, we developed a convenient synthetic approach to novel 5‐arylpyrazole derivatives as potential MCT1 inhibitors. Eleven new pyrazole derivatives ( 17a–k ) were prepared through a six‐step sequence in 5%–19% overall yields. Screening using 3‐bromopyruvate assays revealed that compound 17c, bearing a 3‐fluorophenyl substituent, significantly inhibited MCT1‐mediated transport at below its cytotoxic concentrations. The compound 17c induced dose‐ and time‐dependent accumulation of intracellular lactate in multiple cell lines, confirming its ability to interfere with MCT1‐driven metabolism. These results identify 5‐arylpyrazoles as a promising chemotype of MCT1 inhibitors, and highlight compound 17c as a potential lead for further optimizations in cancer metabolism‐targeted therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Organic Chemistry, Nizhny Novgorod State University, Nizhny Novgorod, Russian Federation.
- Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russian Federation.
- Institute of biology and biomedicine, Nizhny Novgorod State University, Nizhny Novgorod, Russian Federation.
ORCID profiles: Irina P Fonareva, Elena V Svirshchevskaya, Elena V Mitroshina, Alexey Yu Fedorov, Ekaterina S Shchegravina
Funding
- Russian Science Foundation
Cite
APA
Fonareva, I. P., Svirshchevskaya, E. V., Mitroshina, E. V., Marasanova, E. A., Vedunova, M. V., Zaburdaeva, E. A., Fedorov, A. Y., & Shchegravina, E. S. (2026). Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70555
Vancouver
Fonareva IP, Svirshchevskaya EV, Mitroshina EV, Marasanova EA, Vedunova MV, Zaburdaeva EA, et al. Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70555
BibTeX
@article{Fonareva2026,
author = {Fonareva, Irina P and Svirshchevskaya, Elena V and Mitroshina, Elena V and Marasanova, Ekaterina A and Vedunova, Maria V and Zaburdaeva, Elena A and Fedorov, Alexey Yu and Shchegravina, Ekaterina S},
title = {Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {20},
doi = {10.1002/cmdc.70555}
}
EUVIMED